Table 2 Clinical and functional characteristics of evaluated COPD patients (n = 180)
From: Clinical significance in COPD patients followed in a real practice
Dyspnea | 171 (95%) |
|---|---|
Dyspnea Degree 1 (mMRC) | 16 (8.8 % ) |
Dyspnea Degree 2 (mMRC) | 25 (13.8 % ) |
Dyspnea Degree 3 (mMRC) | 92 (51.1 % ) |
Dyspnea Degree 4 (mMRC) | 38 (21.3 % ) |
Chronic Cough | 155 (86.1 % ) |
Sputum Production | 72 (40.0 % ) |
Wheezing | 125 (69.4 % ) |
Post-bronchodilator Spirometry: | Mean ± SD |
FVC (L) | 2.19 ± 0.99 |
FVC (% of predicted) | 75.0 ± 15.0 |
FEV 1 (L) | 1.17 ± 0.52 |
FEV 1 (% of predicted) | 44.81 ± 16.7 |
FEV 1 / FVC (%) | 57 ± 12 |
COPD stage: | N (%) |
GOLD I | 14 (7.8 % ) |
GOLD II | 63 (35.0% ) |
GOLD III | 66 (36.7% ) |
OLD IV | 37 (20.5% ) |